Connexio Health
  • Home
  • Company
    • About
    • History
    • Careers
  • Solutions
    • Downstream Demand Generation
    • Virtual Clinical Education
    • Data Intelligence
    • Virtual Account Management
  • Resources
    • Articles
    • Case Studies
    • Whitepapers
    • Hidden Growth Quiz
    • FAQs
    • Connexio Pulse Podcasts
  • Contact
  • FDA Novel Oncology Drug Approvals in 2025: Key Trends for Developers

    FDA Novel Oncology Drug Approvals in 2025: Key Trends for Developers

    Oncology remained one of the FDA’s most active therapeutic areas in 2025, with novel approvals highlighting the continued shift toward precision medicine, biomarker-driven therapies, and accelerated development pathways. For healthcare manufacturers and developers, the year reinforced the importance of strategic regulatory planning, targeted commercialization, and data-driven execution.

    Precision Medicine Continued to Lead

    Many 2025 oncology approvals focused on highly specific patient populations identified through biomarkers or genetic mutations. Therapies targeting EGFR, KRAS, TROP2, and c-MET pathways demonstrated the FDA’s ongoing support for precision oncology approaches.

    For developers, this means:

    • Earlier integration of companion diagnostics
    • Stronger biomarker validation
    • More focused clinical trial designs
    • Smarter patient segmentation strategies


    ADCs Gained Momentum

    Antibody-drug conjugates (ADCs) continued expanding across oncology indications in 2025. Several approvals highlighted the growing role of ADCs in improving targeted efficacy while reducing systemic toxicity.

    This trend creates new opportunities for:

    • Combination therapies
    • Lifecycle expansion
    • Rare cancer indications
    • Precision-focused commercialization


    Rare Oncology Programs Benefited from Regulatory Flexibility

    Rare and difficult-to-treat cancers remained a priority for the FDA, with many therapies receiving accelerated review support through programs like:

    • Fast Track
    • Accelerated Approval
    • Real-Time Oncology Review (RTOR)
    • Project Orbis

    Developers targeting unmet needs with strong early clinical data continued benefiting from streamlined regulatory pathways.

    AI and Data Strategy Became More Important

    AI and advanced analytics played a larger role in oncology development throughout 2025, supporting:

    • Biomarker discovery
    • Patient recruitment
    • Trial optimization
    • Real-world evidence analysis

    As oncology becomes more data-intensive, developers with strong data infrastructure and analytics capabilities are gaining a competitive advantage.

    Strategic Takeaways for Healthcare Developers

    The 2025 approval landscape reinforced several important themes:

    • Precision medicine is becoming essential, not optional
    • Commercial planning must begin earlier in development
    • Smaller patient populations require more targeted engagement strategies
    • Data quality and patient insights are increasingly tied to launch success

    As oncology innovation accelerates, developers that combine scientific differentiation with agile commercialization strategies will be best positioned for long-term growth.

    Kristen Fescoe

    May 19, 2026
    News
  • The Rules of Visibility in Medical Device Marketing

    The Rules of Visibility in Medical Device Marketing

    Over the past decade, access to healthcare professionals has steadily declined—and the dynamic has only intensified in recent years. More than 40% of physicians have historically refused or heavily restricted access to medical device sales representatives, with this trend accelerating post-COVID.* While some access has returned, it is far more selective, with physicians choosing when, how, and with whom they engage. As a result, the traditional model of broad, in-person coverage is no longer viable. The number of sales reps has declined as marketing leaders reassess reach and frequency strategies, recognizing that flooding the market is ineffective—particularly as a defensive approach. To close these gaps, medical device companies are increasingly relying on non-personal and omnichannel tactics to extend reach and maintain engagement.

    Another study, regarding the frequency at which the most valuable decision makers are contacted, noted this group of doctors is being barraged at a nearly unbelievable average of 2,800 “touches” per year. This translates to 1 contact for every working hour! Apart from the questionable economics of this marketing spend, the question that device sales and marketing leaders need to ask is, “How can this level of uncoordinated communication be anything but noise?”

    In other words, how is it possible for a brand to deliver a message that will be heard above the clutter? As the industry and communication at large evolve through decades of experience and adaptation, we have found a solution based on predicting, testing, gathering insights, and confirming our assumptions. A succinct combination of actions yields success critical for driving bottom-line growth through highly engaged customer experiences — even at mass volume. You are probably wondering: how is that possible? Where do you begin?


    Predictive Analytics

    With a team of seasoned industry experts and access to behavioral history on similar audiences, analysis can be performed to establish an initial hypothesis of what will work best. Most corporations, if they get that far, stop there. They see the desired results, i.e., “above industry average” rates, and the box gets checked off. With analytical expertise, the science of marketing is involved – a plan is developed to test and learn.

    Predictive models use algorithms to process huge quantities of data and relate the probability of a specific result to a specific action. In a simplistic example, if I send an email to a person, what is the likelihood that they will open it? Predictive models, however, can process far more complicated computations to include huge numbers of parameters. For example, if I send an email to a person at a particular time, on a particular day, with a particular subject line, and a particular font, what is the likelihood they will open it as compared to the permutations of other choices?

    Now let’s envision a campaign with 10,000 targets, using 6 marketing channels, over 6 weeks. What sequence of channel outreach will be most effective? Should all the channels be deployed? Are there segments that will respond in different ways to different treatments? And the list of questions goes on…

    What we are trying to do is deploy the assets in a constrained time and resource environment. Predictive models can help determine how to send the right message, with the right channel, at the right time, to the right target, in the right sequence. The assumptions are set up to be challenged. A thirsty team learns by challenging their own assumptions, breaking through, and making new ones as well.



    True Omni-Channel Execution

    When planning a non-personal marketing campaign, marketing executives need to strategically select the most valuable combination of channels, messages, and frequency for their target audience. Oftentimes, a campaign will rely on one channel (typically email), utilize messages that have been “recycled” based on prior approved content, and be delivered at a frequency that is deemed “appropriate” by their agency — but rarely based on data-driven practices. Some brands use advanced models of “headroom” or opportunity space to suggest a higher level of frequency. But in the end, there is typically only marginally differentiated communication among health care professional segments.

    In the past few years, most non-personal campaigns have begun with an assumption that there will be a single communication channel: email. This is due to a belief that email is less expensive and coordinating a multichannel approach is too complex. However, this narrow approach to channel choice contradicts what has long been known about physician preference. That is, doctors have different channel preferences. Some physicians respond more favorably to print, and indeed, telesales reps continue to be an effective resource within the marketing mix.

    Health care professionals tend to want reps that can deliver an expertise in the science the physician works in, as they will not have the time to develop their own proof of case. And if those Clinical experts are not available face-to-face, doctors are now more willing to interact with them via video chat and other remote means. Some companies, especially those with products that demand scientific expertise, have taken a hybrid approach to their field staff, deploying a product team focused on customer service (including access to samples, etc.) and a team of clinical representatives who can speak to the medical device science and practice issues. This multi-pronged strategy to marketing a brand or product can also be used as the framework for content strategy in non-personal tactics.

    The availability of clinical experts can be optimized and extended through the clinical campaign, offering video details or lunch and learns with experts scheduled to best meet the clinicians’ schedule. This training component may be a critical part of the sales process before the determination to purchase or part of the sales promise, sealing the deal by moving from transactional sales to long-term support and partnership. Depending on the device, levels of training capabilities may be a consideration, depending on the role of the trainee or level of services offered at the location. The opportunity for specialization can be a motivating factor from a marketing and training standpoint.


    Rapid Adaptation and Learning

    Once a campaign has been determined and the start button pushed, then real life happens. Our earlier “Predictive Analytics” are built to be broken down, and an expert team knows and looks for campaign signals to respond to such events. In fact, that is where the value of true omni-channel marketing lies. Our “targets” are real people who don’t always behave as mathematical models predict. Rapid adaptation is the ability to change course mid-stream in a campaign, recalculate what the next best action is, and execute it. This level of sophistication has taken decades to achieve through data insights and requires a structured decision engine and, equally important, a truly multi-channel platform capable of performing the actions. Many people market using multiple channels, while a few actually weave the responsive network together for data interaction significance. This approach allows statistical meaning to be found and customers to enjoy a more unique experience.

    At the end of each campaign, we have the opportunity to learn. What worked, what didn’t? Were the models correct? What adaptive paths were created to respond dynamically in real time? Add in market expertise regarding the specific target audiences and ask, is there a reason for an outlier’s behavior? Is a subgroup forming that may benefit from specific target messaging? This end-of-campaign analysis is critical in refining assumptions and feeding data models to optimize prediction and adoption in the next cycle.

    Device sales are unlike pharma. We cannot rely on a single prescription being written. Device sales count on a complex web of individuals who all impact the choice in the end. Economic and clinical decision-makers may rely on speed, accuracy, maintenance, ease of use, return on investment, comfort, and so much more to be delivered by your device to their patients. This means “one- sized messaging does not fit all”. To be successful, you must map out the complete influencer and decision-maker audiences and what your product can provide them. Overlooking an audience may mean losing a sale.

    In the end, the key to initially reaching health care professionals who have reduced access to sales reps is augmenting and replacing the rep with the optimal mix of digital and non-Digital communication tactics that are part of a coordinated whole to deliver meaningful content. This coordinated approach needs to optimize the frequency of touches, the variety of subjects, and the frequency of offers — such as samples or demonstration opportunities. The objective is to optimize communication so there is never a barrage of communications from the same brand, and so messages at an enterprise level appear coordinated. With smart approaches to measuring tactical impact, non-personal communication efforts can be deployed to maximize ROI and reduce the extraneous noise. Of course, this coordinated effort requires a smart CRM system that is driven and guided by actual healthcare professional behavior. When marketers know how their campaigns are stimulating what matters to their customers, then those campaigns can be tuned so that they are optimized for the best effect.

    Having access to data insights means you know the doctor is seeing you, even though you’re not seeing them.


    Stephanie Andacht joined Modern Marketing Concepts in 1992 and proudly claims a proven record of progressive sales leadership within the organization. As VP of Strategic Accounts, she applies her deep industry knowledge to partnerships with some of the company’s most valuable pharmaceutical, medical device, and diagnostic clients.

    * https://tealium.com/blog/data-strategy/no-see-healthcare-professionals-hcps-and-how-to-engage-them/?utm_source=chatgpt.com

    Kristen Fescoe

    April 23, 2026
    Marketing
  • The Patient Journey Is Being Re-Routed—and AI Is Leading the Way

    The Patient Journey Is Being Re-Routed—and AI Is Leading the Way

    More patients aren’t starting with their doctor anymore. They’re starting with AI.

    This shift is already happening at scale. Roughly 1 in 4 U.S. adults has used AI for health advice, driven by cost, access barriers, and the need for faster answers.

    That statistic points to something bigger than adoption. It signals a fundamental change in where the patient journey begins.



    A New Front Door to Healthcare

    For years, the journey started inside the system—with a visit, a referral, or a scheduled interaction.

    Now, it often starts before any of that.

    Patients are turning to AI to understand symptoms, explore treatment options, and shape decisions before engaging a provider. In effect, AI has become the first touchpoint—the front door to healthcare.

    But that front door exists outside the system itself.



    The Growing Tension

    Adoption is accelerating, but trust is still catching up.

    Patients value speed and accessibility, yet questions remain around accuracy and reliability. At the same time, healthcare organizations are under pressure to integrate AI, reduce burnout, and expand access without adding resources.

    The result is a disconnect: while systems are evolving internally, the patient journey is already shifting externally.



    More Than Digital—A Structural Shift


    This isn’t just digital transformation. It’s a rerouting.

    The journey is moving from provider-led to patient-initiated, from controlled interactions to always-on access. And that shift changes how organizations think about engagement, education, and growth.



    Who Owns the Journey?

    The question is no longer whether AI will play a role—it already does.

    The real question is:

    Who owns the patient journey when it starts before the system?

    Because ownership now begins at the moment of curiosity, not the moment of care.

    Organizations that adapt to this reality will influence decisions earlier and engage more effectively. Those who don’t risk falling behind in a journey that’s already in motion.



    Redefining Access

    This shift isn’t just about engagement—it’s about redefining access.

    In a world where the journey starts outside your walls, growth depends on reaching patients earlier, guiding them better, and meeting them where they are.

    Not after they enter the system—but before they ever do.

    Kristen Fescoe

    April 16, 2026
    News
  • The Hidden Growth Channel™ in Healthcare: Where Revenue Is Already Waiting

    The Hidden Growth Channel™ in Healthcare: Where Revenue Is Already Waiting

    Most healthcare manufacturers are built on strong fundamentals: solid products, capable field teams, and established customer relationships. But even when the core business is performing, revenue doesn’t automatically “compound” across the market.

    It stalls in the places teams can’t consistently reach.

    That’s where the Hidden Growth Channel comes in.

    The Hidden Growth Channel is the revenue potential that already exists inside your commercial ecosystem—accounts you’ve touched before, markets that show demand signals, customers who are at risk of drifting, or segments that never receive enough follow-through to convert. It’s not a pipeline problem. It’s an execution capacity problem.

    In healthcare, this shows up in familiar ways:

    • Territories that remain undercovered because field teams must prioritize top accounts
    • High-value accounts that need more touches than reps can sustain
    • Referral networks and community settings that influence demand but sit outside the “core list”
    • Launch and lifecycle moments where the right follow-through is difficult to scale
    • Existing accounts with unrealized cross-sell or expansion potential

    The opportunity is there—but it’s distributed across systems, geographies, and decision-makers. And it changes constantly.

    Why this matters now

    Healthcare manufacturers are operating in an environment where expectations are rising, but execution bandwidth is not.

    Field teams are stretched. Access is complex. Stakeholders are fragmented. And “more campaigns” rarely solve the real issue: consistent follow-through at scale.

    The Hidden Growth Channel reframes the question from:

    • “What should we do next?” to
    • “Where is revenue already embedded in our footprint—and what execution would unlock it?”

    At Connexio Health, we see Hidden Growth as a practical execution problem—not a marketing concept.

    The work starts by uncovering where opportunity exists across your footprint, then extending execution capacity to the decision moments that matter most—without adding permanent headcount or creating noise. And it only works if outcomes are measurable.

    Because in a market as complex as healthcare, growth doesn’t stall from a lack of strategy.

    The next step is simple: identify where revenue is already embedded in your footprint—and determine what execution will unlock it.

    Kristen Fescoe

    March 30, 2026
    Connexio Health, News
  • Whitespace Growth in Healthcare: How to Expand Coverage Without Expanding Headcount

    Whitespace Growth in Healthcare: How to Expand Coverage Without Expanding Headcount

    In healthcare commercialization, growth is often tied to expansion—more territory coverage, more field representatives, and more operational infrastructure. But many organizations reach a point where expanding the team becomes increasingly difficult due to budget constraints, hiring timelines, or operational complexity.

    At the same time, revenue opportunities continue to exist in markets that fall outside the reach of existing field teams.

    This is where whitespace strategy becomes essential.

    A healthcare whitespace strategy focuses on identifying and activating opportunities that exist beyond the core territory footprint. Instead of expanding headcount, organizations can extend their commercial reach through smarter coverage models that increase engagement across underserved markets.

    The result is expanded sales coverage without the operational burden of scaling a traditional field organization.


    What “Whitespace” Actually Means in Pharma and Medical Device

    In pharmaceutical and medical device organizations, whitespace refers to healthcare providers, institutions, or geographic markets that are not actively engaged by the existing sales team.

    These gaps occur for several reasons:

    • Territory sizes exceed what field representatives can realistically cover
    • Lower-volume accounts receive limited or no engagement
    • Newly identified providers fall outside existing targeting models
    • Expansion into new specialties or clinical segments creates uncovered opportunities

    Field teams naturally prioritize high-value accounts within their territories. As a result, entire segments of the market remain largely untouched, even though they represent legitimate revenue potential.

    Whitespace is not just unused territory—it is unrealized commercial capacity within the healthcare market.

    Organizations that identify and activate these opportunities can unlock growth without disrupting their core field strategy.


    Why Territory Maps Hide Revenue

    Traditional territory maps are designed to organize sales teams, not necessarily to maximize market coverage.

    On paper, territories often appear fully covered. In reality, they contain large pockets of under-engagement.

    Several structural factors contribute to this hidden whitespace:

    1. Limited Field Capacity
    A typical field representative can only engage a fraction of the providers within a territory. Travel time, scheduling limitations, and administrative responsibilities restrict the number of meaningful interactions possible each week.

    2. Account Prioritization
    Reps understandably focus on their highest-value accounts. This means smaller or emerging opportunities receive little attention, even if they collectively represent significant revenue.

    3. Expanding Provider Networks
    Healthcare provider databases grow constantly as new practices, specialists, and treatment centers emerge. Territory planning rarely keeps pace with these changes.

    4. Coverage Gaps Between Territories
    Certain markets sit between territories or across organizational boundaries, creating areas where no team is clearly responsible for engagement.

    When organizations evaluate their coverage at the provider level rather than the territory level, they often discover that large portions of the addressable market remain untouched.


    Cost Comparison: FTE vs. Continuous Execution

    The most common response to coverage gaps is to hire additional field representatives. While effective in some cases, expanding the field team is one of the most expensive and time-consuming ways to increase coverage.

    A typical healthcare field representative carries substantial total cost once salary, benefits, travel, management overhead, and onboarding are included.

    Beyond cost, organizations must also consider:

    • Recruitment timelines
    • Territory realignment complexity
    • Ramp-up periods before productivity begins
    • Long-term headcount commitments

    For many organizations, these constraints make hiring impractical for addressing smaller or fragmented whitespace markets.

    An alternative approach is continuous execution models, which extend coverage across underserved accounts without requiring permanent headcount expansion.

    Instead of assigning a dedicated representative to a fixed territory, organizations deploy structured engagement programs that systematically reach providers outside the core field footprint.

    This allows companies to expand sales coverage without hiring additional full-time staff while maintaining operational flexibility.


    The Operational Model Behind Expanded Coverage

    Expanding coverage without adding headcount requires a structured execution model designed specifically for whitespace markets.

    These models typically include several operational components:

    Target Identification

    The first step is identifying the providers or accounts that fall outside current engagement patterns.

    This requires combining multiple datasets—including prescribing data, provider affiliations, and market activity—to pinpoint where engagement is missing but opportunity exists.

    Advanced segmentation can also identify emerging specialists or previously overlooked practices.

    Structured Outreach Programs

    Once targets are identified, organizations deploy engagement programs designed to reach these providers through scalable touchpoints.

    This can include:

    • Virtual clinical engagement
    • targeted education programs
    • digital outreach
    • remote account management

    These programs provide consistent engagement without requiring the travel and scheduling constraints of traditional field activity.

    Alignment With Field Sales

    Whitespace programs work best when they complement—not compete with—the existing field team.

    High-value opportunities identified through expanded coverage can be transitioned back to field representatives for deeper relationship development.

    This approach ensures that expanded coverage supports the field rather than replacing it.

    Continuous Market Monitoring

    Whitespace opportunities evolve as markets change. A successful model continuously evaluates engagement data and adjusts targeting to maintain efficient coverage.

    The goal is not simply to fill gaps once, but to create an ongoing channel for commercial execution beyond the core field footprint.


    Metrics That Matter

    Organizations evaluating whitespace strategies should focus on metrics that reflect true coverage expansion rather than simple activity volume.

    Key performance indicators include:

    Market Coverage Rate
    The percentage of addressable providers actively engaged within a given timeframe.

    Reach and Frequency
    How many unique providers are engaged and how consistently they are contacted.

    Opportunity Identification
    New accounts, prescribing activity, or referral patterns discovered through expanded engagement.

    Cost of Coverage
    The cost required to reach each additional provider compared to traditional field engagement.

    Revenue Contribution
    Incremental sales or prescribing activity generated from previously unengaged accounts.

    When tracked consistently, these metrics provide a clear view of whether a whitespace strategy is successfully expanding commercial reach.


    Turning Whitespace Into Growth

    Healthcare markets are rarely fully covered, even when territory maps suggest otherwise. Beneath those maps are thousands of providers and institutions that receive little or no engagement.

    Organizations that recognize this gap can unlock growth by expanding coverage through structured execution models rather than traditional headcount expansion.

    By identifying underserved accounts, deploying scalable engagement programs, and aligning these efforts with field teams, healthcare companies can activate previously unreachable parts of the market.

    Whitespace is not simply unused territory—it is an opportunity to extend commercial reach and capture growth that would otherwise remain hidden.

    Kristen Fescoe

    March 4, 2026
    Marketing, Connexio Health, Healthcare Manufacturing, Non-Personal Promotion, VSO, Whitespace
  • Building Execution That Moves as Fast as Healthcare Markets Do

    Building Execution That Moves as Fast as Healthcare Markets Do

    By the time February arrives, most healthcare organizations have done the hard work of planning. Goals are set. Priorities are aligned. Strategies are documented.

    And yet, this is often when momentum starts to slow.

    The challenge isn’t a lack of vision. It’s execution.

    Many teams struggle to translate strategy into action—not because the plan is flawed, but because the structure behind execution doesn’t support speed, flexibility, or iteration.

    Why Strategy Alone Isn’t Enough

    Healthcare commercialization is rarely linear. Markets evolve, data shifts, and priorities change faster than traditional sales and marketing models can adapt.

    When execution structures are built too rigidly or too early, teams often experience:

    1. Delays caused by long hiring and onboarding cycles
    2. Fixed resources committed before strategies are validated
    3. Difficulty adjusting when assumptions change

    As a result, even strong strategies can stall before they gain traction.

    Execution Requires the Right Structure

    Effective execution isn’t about doing more—it’s about doing the right things, at the right time, with the right level of support.

    Successful healthcare teams build execution models that are:

    1. Measured: Progress is tracked, evaluated, and refined
    2. Flexible: Resources can scale up or down as needs evolve
    3. Iterative: Learnings are applied quickly, not annually

    This is where many organizations begin to rethink how sales and marketing support is deployed.

    How Fractional Teams Bridge the Gap

    Fractional sales and marketing teams play a critical role in closing the gap between strategy and execution.

    Rather than committing to full internal builds upfront, fractional models allow healthcare organizations to:

    1. Activate sales and marketing programs quickly
    2. Access experienced talent without long ramp times
    3. Adjust scope as priorities shift
    4. Reduce risk while maintaining momentum

    Fractional teams are not a temporary fix—they are a strategic way to operationalize growth without overbuilding.

    Turning ICPs Into Real-World Execution

    Ideal Customer Profiles (ICPs) are often well-defined on paper but underutilized in execution.

    When ICPs are actively embedded into sales and marketing efforts, teams can:

    1. Prioritize the right accounts and segments
    2. Align messaging and outreach
    3. Improve engagement quality and efficiency

    Execution accelerates when ICPs are treated as operational tools—not static documents.

    From Planning to Momentum

    February is a critical inflection point. It’s where strategy either turns into sustained progress—or stalls under the weight of overbuilt models.

    For healthcare organizations looking to operationalize growth, the goal isn’t to build bigger teams. It’s to build smarter execution—designed to adapt, evolve, and scale when the time is right.

    Opportunity creates potential. Execution turns it into results.

    Kristen Fescoe

    February 9, 2026
    Uncategorized
  • Healthcare Trends to Watch in 2026

    Healthcare Trends to Watch in 2026

    Healthcare is entering a defining moment. Cost pressure, digital acceleration, evolving patient expectations, and new care models are converging—forcing organizations to rethink how care is delivered, financed, and communicated. As we look toward 2026, several trends stand out as especially important for healthcare leaders and marketers alike.

    1. Cost pressure drives value-focused strategies

    Rising healthcare costs are no longer a short-term issue. Employers, payers, and providers are under sustained pressure to demonstrate value. In 2026, success will depend less on volume and more on measurable outcomes, efficiency, and total cost of care. For healthcare organizations, this means clearly articulating how services improve outcomes while controlling costs.

    2. AI moves from experimentation to execution

    Artificial intelligence is shifting from pilot programs to operational use cases—supporting diagnostics, forecasting, population health, and patient engagement. At the same time, trust, governance, and transparency will be critical as regulation and scrutiny increase. AI will also reshape how patients search for information, making content clarity and credibility more important than ever.

    3. Care continues moving beyond traditional settings

    Home-based, virtual, and community-based care models will expand further in 2026. Patients increasingly expect care to fit into their lives, not the other way around. This shift emphasizes convenience, access, and continuity—while also helping organizations manage costs and capacity.

    4. Patients behave more like informed consumers

    Healthcare consumers are digitally savvy, research-driven, and expect seamless experiences across channels. From AI-powered search to mobile-first engagement, organizations must meet patients where they are with clear, personalized, and easy-to-understand information. Trust and transparency will remain central to engagement.

    5. Payment and reimbursement models keep evolving

    Value-based care, alternative payment models, and employer-driven benefit changes will continue shaping healthcare strategy. Organizations that can clearly align services with evolving reimbursement structures—and explain that alignment simply—will be better positioned for growth.

    6. Workforce redesign influences care delivery

    Staffing shortages and burnout are driving new care team models, increased virtual care, and technology-enabled workflows. These changes will affect how care is delivered and experienced, requiring organizations to align their messaging with new realities on the front lines.

    7. Precision medicine and advanced diagnostics grow

    Advances in genomics, diagnostics, and targeted therapies are accelerating. As care becomes more personalized, education becomes essential—helping patients, providers, and payers understand what these innovations mean in real-world outcomes.

    8. Data security and trust become differentiators

    As healthcare becomes more digital, cybersecurity, data governance, and privacy are no longer behind-the-scenes concerns. Organizations that proactively communicate how they protect data and use technology responsibly will stand out.

    9. Health equity remains a strategic priority

    Addressing social determinants of health and improving access for underserved populations will continue shaping care strategies. Equity-focused initiatives are no longer optional—they influence outcomes, trust, and brand credibility.

    What this means heading into 2026

    The healthcare organizations that succeed in 2026 will be those that balance innovation with trust, technology with human connection, and growth with measurable value. For marketers and strategists, the opportunity lies in translating complexity into clarity—helping stakeholders understand not just what is changing, but why it matters.

    Kristen Fescoe

    January 21, 2026
    News, Connexio Health
  • A Smarter Way to Scale in the New Year: Rethinking Sales and Marketing in Healthcare 

    A Smarter Way to Scale in the New Year: Rethinking Sales and Marketing in Healthcare 

    January brings renewed energy—and renewed pressure. New budgets are approved, goals are set, and leadership teams feel the urgency to move quickly. For many healthcare organizations, that urgency translates into a familiar response: hire more people, build larger teams, and scale fast. 

    But speed doesn’t always come from size. And growth doesn’t always require permanent headcount. 

    More healthcare organizations are starting the year with a different mindset—one focused on flexibility, focus, and right-sized execution. 

    The Pressure to Build Fast in January 

    The start of the year often feels like a race against the calendar. Commercial teams are expected to show momentum early, validate investments quickly, and demonstrate progress before Q2 even begins. 

    In that environment, traditional sales and marketing models can create friction: 

    1. Long hiring timelines delay execution 
    2. Fixed costs are committed before strategies are fully validated 
    3. Teams are built for scale before focus is established 

    The result is often overextension—resources deployed broadly, but not always effectively. 

    The Evolving Role of Traditional Commercial Models

    Healthcare markets are complex, highly regulated, and rarely predictable. Yet many commercial models are designed as if growth will follow a straight line. 

    Common challenges include: 

    1. Inflexibility: Once teams are built, it’s difficult to adjust quickly 
    2. Misalignment: Sales and marketing resources may outpace strategy 
    3. Risk concentration: Significant investment is made before outcomes are clear 

    When execution begins before clarity is established, even well-funded initiatives can stall. 

    The Rise of Fractional Sales and Marketing in Healthcare 

    Fractional sales and marketing models have gained traction not because they are cheaper—but because they are smarter. 

    At their core, fractional partnerships offer healthcare organizations: 

    1. Access to experienced commercial talent without long ramp times 
    2. The ability to scale support up or down as needs evolve 
    3. Faster execution with lower upfront risk 

    Rather than committing to a fixed structure, organizations can build commercial support that adapts alongside the business. 

    Choosing the Right Model for the Moment 

    Not every organization needs the same level of support at the same time. The most effective commercial strategies align structure to stage. 

    That may include: 

    1. Full-scale sales and marketing programs for organizations ready to expand coverage and accelerate growth 
    2. Project-based engagements to support launches, pilots, or targeted initiatives 
    3. Flexible 1099 teams that expand reach without long-term commitments 

    Each approach serves a different purpose. The key is matching the model to the opportunity in front of you—not defaulting to scale too early. 

    Start with Clarity Before Scale 

    Before adding resources, one foundational question must be answered: 

    Who are you really trying to reach? 

    Clear Ideal Customer Profiles (ICPs) create focus across sales and marketing by: 

    1. Aligning messaging and engagement 
    2. Prioritizing the right accounts and segments 
    3. Reducing wasted effort and misdirected spend 

    Without this clarity, even the most robust teams struggle to generate meaningful results. Strategy must lead execution—not the other way around. 

    Build Smarter This Year 

    The start of the year is a natural moment to reassess—not just goals, but how those goals will be achieved. 

    For many healthcare organizations, the smartest path forward isn’t about building bigger teams. It’s about building the right model—one that supports momentum today and adapts as the business evolves. 

    Growth doesn’t have to be all or nothing.  And January doesn’t have to be about overcommitting. 

    Sometimes, the strongest move is choosing flexibility first. 

    Kristen Fescoe

    January 16, 2026
    Uncategorized
  • Why Fractional Teams Are a Smart Solution for Healthcare Companies

    Why Fractional Teams Are a Smart Solution for Healthcare Companies

    Healthcare companies today face a difficult balancing act: growing efficiently while managing rising costs, complex regulations, and rapidly changing market demands. For many organizations, building large, full-time teams is no longer the most practical—or sustainable—option. That’s where fractional teams come in.


    Fractional teams provide specialized expertise on a flexible, scalable basis, allowing healthcare companies to access the skills they need without the overhead of permanent hires. Whether it’s marketing, data analytics, clinical education, commercialization support, or operations, fractional models offer a smarter way to move forward.

    One of the biggest advantages is speed to impact. Fractional professionals are typically seasoned experts who can step in quickly, understand the landscape, and start delivering value without lengthy onboarding or training cycles. This is especially important in healthcare, where timing—whether for a product launch, market expansion, or education initiative—can significantly affect outcomes.

    Cost efficiency is another major benefit. Instead of committing to full salaries, benefits, and long-term headcount, organizations pay for only what they need, when they need it. This makes fractional teams particularly attractive for companies navigating budget constraints, pilot programs, or fluctuating demand.

    Fractional teams also offer flexibility and adaptability. As priorities shift, teams can scale up or down, add new capabilities, or refocus efforts without disruption. This agility supports smarter decision-making and reduces the risk of overbuilding internal resources that may not be needed long-term.

    Finally, fractional models encourage a results-oriented mindset. With clearly defined scopes and goals, teams are aligned around outcomes rather than roles, helping healthcare organizations stay focused on performance, efficiency, and measurable progress.

    In an industry where complexity is the norm and change is constant, fractional teams provide a practical, modern solution—delivering expertise, flexibility, and impact without unnecessary burden.

    Kristen Fescoe

    January 6, 2026
    Non-Personal Promotion, Healthcare Manufacturing, Marketing, VSO
  • The Rising Importance of GEO in Healthcare Marketing

    The Rising Importance of GEO in Healthcare Marketing

    As AI-driven search becomes a primary source of information for healthcare professionals and decision-makers, Generative Engine Optimization (GEO) is emerging as a critical advantage for organizations across the industry. Traditional SEO still matters, but it can no longer account for how generative engines interpret expertise, evaluate credibility, and surface recommendations.

    Healthcare buyers—from physicians to commercial teams—are increasingly turning to AI for fast, accurate insights. Organizations that understand GEO will position themselves at the center of these conversations, shaping how their solutions, capabilities, and perspectives are represented in AI-powered environments.

    Why GEO Matters More in Healthcare Than in Any Other Industry

    Generative AI is becoming a primary research tool for:

    • Physicians seeking clinical or educational resources
    • Commercial teams evaluating new solutions
    • MedTech and Pharma leaders exploring market trends
    • Healthcare executives researching commercialization models
    • Procurement and supply chain assessment capabilities

    These audiences value accuracy, speed, and clarity. GEO ensures your content aligns with how they now search for solutions.

    Healthcare also carries a higher burden of trust. Generative tools amplify information that is consistent, evidence-based, and strategically differentiated—exactly what healthcare buyers expect.

    Organizations that fail to adopt GEO risk are becoming invisible in the channels where decisions increasingly begin.

    How Healthcare Companies Can Implement GEO Today

    Here are practical steps to begin shifting from SEO-first to SEO + GEO:

    1. Rewrite high-value content for AI comprehension

    Prioritize clarity over creativity. Define terms, explain processes, and break complex topics into structured sections.

    2. Publish content that answers real decision-making questions

    GEO thrives on content that mirrors the queries healthcare leaders ask every day:

    • How do we expand reach?
    • What models can reduce commercialization waste?
    • How should we evaluate whitespace opportunities?

    3. Strengthen your thought-leadership frameworks

    Develop repeatable narratives—your methodology, philosophy, and approach to transformation. Consistency equals authority in AI environments.

    4. Leverage data, examples, and case studies

    AI platforms reward trustworthy evidence. Highlight outcomes, not just recommendations.

    5. Refresh content regularly

    Generative systems prioritize current insights. Outdated perspectives lower your visibility.

    The Future: GEO as a Competitive Advantage in Healthcare

    The shift from SEO to GEO represents a fundamental change in healthcare marketing. Organizations that adapt early will gain a disproportionate advantage—becoming the sources AI tools reference, cite, and recommend.

    At a time when commercialization teams face tighter budgets, shifting buyer behaviors, and rapid market transformation, GEO ensures your expertise is accessible wherever decisions are made.

    Healthcare leaders who embrace GEO aren’t just optimizing content. They’re future-proofing their brand.

    Kristen Fescoe

    January 5, 2026
    Marketing, Non-Personal Promotion
1 2 3 … 5
Next Page
  • 607-545-4010
  • info@connexiohealth.com
  • FAQs
  • Privacy Policy
  • Terms & Conditions
  • Facebook
  • https://twitter.com/ConnexioHealth
  • Instagram
  • YouTube
  • LinkedIn